Bellerophon Therapeutics, Inc.: common_shares_issued
| Value | {"unit": "shares", "value": 32988683, "concept": "us-gaap:CommonStockSharesIssued"} |
|---|---|
| Period | (as of 2017-03-31) |
| Status | current |
| Entity | Bellerophon Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f7781f85-425e-4e32-ab65-79415757640e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001600132-17-000050 · Open the official SEC filing →Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001600132/common-shares-issued/2017-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f7781f85-425e-4e32-ab65-79415757640e
History
- no predecessors — first report